MedTrace Logo

Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face

NCT03393494 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 825

Last updated 2021-11-08

Study results available
· View outcomes & findings →

Summary

To compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment of Acne Vulgaris

Conditions

  • Acne Vulgaris

Interventions

DRUG

Adapalene and Benzoyl Peroxide Topical Gel

Test product

DRUG

Epiduo Topical Product

RLD product

DRUG

Placebo

Placebo gel

Sponsors & Collaborators

  • Padagis LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-13
Primary Completion
2018-09-30
Completion
2019-01-05
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03393494 on ClinicalTrials.gov